Product News and Recalls

Yaz maker Bayer bidding on pricey acquisition

According to Bloomberg, German corporation Bayer is bidding on Pfizer’s animal-health unit.

Bayer’s chief financial officer said last month that the company planned to cut its debt by $1.3 billion to give it more flexibility for a potential takeover.

According to the report, the Pfizer unit could fetch between $14 billion and $18 billion.

See the report here:

Bayer is the manufacturer of Yaz, Yasmin, Beyaz, and Ocella — birth control pills that contain the compound drospirenone.

Those pills have served as the basis of many lawsuits from plaintiffs who claim they weren’t adequately warned of the drug’s harmful side effects, including an increased risk of potentially lethal blood clots, strokes, and pulmonary embolisms.

If you or someone you love developed a blood clot, stroke, or pulmonary embolism while taking Yaz, Yasmin, Beyaz, or Ocella, you may be eligible to recover damages. Contact Lopez McHugh for a free consultation.